Literature DB >> 2807369

Density heterogeneity of eosinophil leucocytes: induction of hypodense eosinophils by platelet-activating factor.

T Yukawa1, C Kroegel, P Evans, T Fukuda, K F Chung, P J Barnes.   

Abstract

We have examined the induction of hypodense eosinophils by platelet-activating factor (PAF), a mediator which may be involved in eosinophil activation in allergic diseases. Guinea-pig eosinophils were incubated with buffer or PAF and applied to continuous Percoll density gradients. Cellular density ranged from 1.0142 to 1.1369 g/ml. Peak eosinophil density in control was 1.0887 +/- 0.0008 g/ml (mean +/- SEM), and 91.1 +/- 1.4% of eosinophils were distributed between 1.0810 and 1.1000 g/ml. Preincubation of eosinophils with PAF(10(-7) M) resulted in a time-dependent and non-cytolytic increase of the number of hypodense eosinophils, with peak densities after incubation for 1 hr and 2 hr of 1.0834 +/- 0.0014 (n = 4, P less than 0.05) and 1.0755 +/- 0.0007 g/ml (n = 6, P less than 0.01), respectively. After incubation for 2 hr, 82.0 +/- 4.9% (n = 6) eosinophils showed a density lower than 1.080 g/ml. Lyso-PAF, the inactive precursor and metabolite of PAF, at a concentration of 10(-7) M had no effect on cell density. The specific PAF receptor antagonist WEB 2086 (10(-6) M) inhibited the PAF-induced density shift by 87.0 +/- 5.3%. Our results demonstrate that a single mediator is able to induce the formation of hypodense eosinophils. We conclude that the appearance of hypodense eosinophils in allergic diseases such as asthma may occur, at least in part, in response to inflammatory mediators which activate these cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2807369      PMCID: PMC1385519     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  The effects of eosinophil activating factor on IgG-dependent sulphidopeptide leukotriene generation by human eosinophils.

Authors:  P Fitzharris; R Moqbel; K J Thorne; B A Richardson; A Hartnell; O Cromwell; A E Butterworth; A B Kay
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

2.  Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.

Authors:  A J Wardlaw; R Moqbel; O Cromwell; A B Kay
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

3.  Increased biosynthesis of platelet-activating factor in activated human eosinophils.

Authors:  T Lee; D J Lenihan; B Malone; L L Roddy; S I Wasserman
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

4.  Increased numbers of hypodense eosinophils in the blood of patients with bronchial asthma.

Authors:  T Fukuda; S L Dunnette; C E Reed; S J Ackerman; M S Peters; G J Gleich
Journal:  Am Rev Respir Dis       Date:  1985-11

5.  Leukotriene C4 production by normal-density and low-density eosinophils of atopic individuals and other patients with eosinophilia.

Authors:  H F Kauffman; B van der Belt; J G de Monchy; H Boelens; G H Koëter; K de Vries
Journal:  J Allergy Clin Immunol       Date:  1987-04       Impact factor: 10.793

6.  Role of IgE receptors in effector function of human eosinophils.

Authors:  M Capron; H L Spiegelberg; L Prin; H Bennich; A E Butterworth; R J Pierce; M A Ouaissi; A Capron
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

7.  Role of specific IgE antibodies in peroxidase (EPO) release from human eosinophils.

Authors:  J Khalife; M Capron; J Y Cesbron; P C Tai; H Taelman; L Prin; A Capron
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

8.  Platelet-activating factor (PAF-acether) induced leukotriene C4 formation and luminol dependent chemiluminescence by human eosinophils.

Authors:  P L Bruynzeel; L Koenderman; P T Kok; M L Hameling; J Verhagen
Journal:  Pharmacol Res Commun       Date:  1986-08

9.  Release of leukotriene C4 from human eosinophils and its relation to the cell density.

Authors:  T Kajita; Y Yui; H Mita; N Taniguchi; H Saito; T Mishima; T Shida
Journal:  Int Arch Allergy Appl Immunol       Date:  1985

10.  Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts.

Authors:  W F Owen; M E Rothenberg; D S Silberstein; J C Gasson; R L Stevens; K F Austen; R J Soberman
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

View more
  7 in total

Review 1.  The role of eosinophils in asthma.

Authors:  C Kroegel
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 2.  PAF. A review of its effects, antagonists and possible future clinical implications (Part II).

Authors:  M Koltai; D Hosford; P Guinot; A Esanu; P Braquet
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

3.  A simple centrifugation method for harvesting myeloblasts.

Authors:  K Ogata
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

4.  Morphology and density features of eosinophil leukocytes in eosinophilic pneumonia. A case report.

Authors:  C Kroegel; H Matthys; U Costabel
Journal:  Clin Investig       Date:  1992-05

5.  Induction of lung eosinophilia and neutrophilia in guinea pigs following injection of sephadex beads.

Authors:  K Maghni; F Blanchette; P Sirois
Journal:  Inflammation       Date:  1993-10       Impact factor: 4.092

6.  Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics.

Authors:  C Kroegel; H Matthys
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

Review 7.  Role for platelet-activating factor in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.